DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01313819 (ClinicalTrials.gov)	April 2011	10/3/2011	The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy	A Double Blind, Placebo-controlled Study for the Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy	Parkinson`s Disease;Freezing of Gait	Drug: PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj	Seoul National University Hospital	NULL	Recruiting	30 Years	80 Years	Both	20	Phase 4	Korea, Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

April 2011

10/3/2011

The Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy

A Double Blind, Placebo-controlled Study for the Effect of IV Amantadine on Freezing of Gait (FOG) Resistant to Dopaminergic Therapy

Parkinson`s Disease;Freezing of Gait

Drug: PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj

Seoul National University Hospital

NULL

Recruiting

30 Years

80 Years

Both

Phase 4

Korea, Republic of